Peptide Based Cancer Therapeutics Market Outlook for Precision Medicine
Valued at USD 8.58 billion in 2019, the peptide based cancer therapeutics market is projected to reach USD 17.18 billion by 2027, growing at a CAGR of 9.1% during the forecast period 2020–2027. Growth is attributed to innovations in peptide based cancer treatment approaches, the growing prevalence of different cancer types, high-efficacy peptide drugs, and rising pharmaceutical interest...
0 Commentarii 0 Distribuiri 207 Views 0 previzualizare